Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
PHASE2
RATIONALE: Drugs used in chemotherapy, such as floxuridine and dexamethason...
Status
Completed
Location
New York Weill Cornell Cancer Center at Cornell University
A Phase II, Single-Arm, Prospective Trial on the Efficacy and Safety of QL1706 Combination Regimen as Second-Line Therapy for Targeted-Immunotherapy-Resistant Hepatocellular Carcinoma
PHASE2
The goal of this prospective Phase II clinical trial is to evaluate the eff...